2013 91 2504- 11.the nih hmp working group peterson j. garges s. giovanni m. mcinnes p. wang l. schloss j. a. bonazzi v. mcewen j. e. wetterstrand k. a. deal c. baker c. c. di francesco v. howcroft t. k. karp r. w. lunsford r. d. wellington c. r. belachew t. wright m. giblin c. david h. mills m. salomon r. mullins c. akolkar b. begg l. davis c. grandison l. humble m. khalsa j. little a. r. peavy h. pontzer c. portnoy m. sayre m. h. starke-reed p. zakhari s. read j.watson b. guyer m. the nih human microbiome project.

2009 19 2317-23.rinke c. schwientek p. sczyrba a. ivanova n. n.anderson i. j. cheng j. f. darling a. malfatti s. swan b. k. gies e. a. dodsworth j. a. hedlund b. p. tsiamis g. sievert s. m. liu w. t. eisen j. a. hallam s. j. kyrpides n. c. stepanauskas r. rubin e. m. hugenholtz p. woyke t. insights into the phylogeny and coding potential of microbial dark matter.

d. goodman a. l. henrissat b. oozeer r. cools-portier s. gobert g. chervaux c. knights d. lozupone c. a. knight r. duncan a. e. bain j. r. muehlbauer m. j. newgard c. b. heatha.

2008 54 19-24.alexopoulos c. georgoulakis i. e. tzivara a. kyriakis c. s. govaris a. kyriakis s. c. field evaluation of the effect of a probiotic- containing bacillus licheniformis and bacillus subtilis spores on the health status performance and carcass quality of grower and finisher pigs.

2008 46 suppl2 s73-s75 discussion s144-51..hungin a. p. mulligan c. pot b. whorwell p. agreus l. fracasso p. lionis c. mendive j. philippart de foy j. m. rubin g. winchester c. de wit n. european society for primary care g. systematic review probiotics in the management of lower gastro- intestinal symptoms in clinical practice - an evidence-based interna- tional guide.

2006 58 85-94.tseng d. y. ho p. l. huang s. y. cheng s. c. shiu y. l. chiu c. s. liu c. h. enhancement of immunity and disease resistance in the white shrimp litopenaeus vannamei by the probiotic bacillus subtilis e20.

2007 90 2058-68.bletz m. c. loudon a. h. becker m. h. bell s. c.woodhams d. c. minbiole k. p. harris r. n. mitigating amphibian chytridiomycosis with bioaugmentation characteristics of effective probiotics and strategies for their selection and use.

2017 11 426-438.reygner j. joly condette c. bruneau a. delanaud s. rhazi l. depeint f. abdennebi-najar l. bach v. mayeur c. khorsi- cauet h. changes in composition and function of human intestinal microbiota exposed to chlorpyrifos in oil as assessed by the shimer model.

2011 11 1956-63.chervaux c. grimaldi c. bolotin a. quinquis b. legrain-raspaud s. van hylckama vlieg j. e. denariaz g. smokvina t. genome sequence of the probiotic strain bifidobacterium animalis subsp.

msphere 2016 1 e00057- 16.patro j. n. ramachandran p. lewis j. l. mammel m. k. barnaba t. pfeiler e. a. elkins c. a. development and utility of the fda 'gutprobe' dna microarray for identification genotyping and metagenomic analysis of commercially available probiotics.

2012 10 66-78.yilmaz b. portugal s. tran t. m. gozzelino r. ramos s.gomes j. regalado a. cowan p. j. d'apice a. j. chong a. s. doumbo o. k. traore b. crompton p. d. silveira h. soares m.p.

bed bench 2014 7 156-163.yamaguishi c. t. spier r. m. lindner j. d. d. soccol v. t. r s. c. current market trends and future directions.

1977 41 449-474.tao l. zhu f. qin c. zhang c. chen s. zhang p. zhangc.

tan c. gao c. chen z. jiang y. chen y. z. clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.

2009 26 339-44.dimitroglou a. merrifield d. l. carnevali o. picchietti s. avella m. daniels c. guroy d. davies s. j. microbialmanipulations to improve fish health and production-a mediterranean perspective.

